Summary:

We’ve been hearing bits and pieces about Draths Corp., a bio-chemical engineering startup, in various speeches from venture investor Vinod Khosla. He hasn’t divulged too much information about the company, only that it was in his portfolio and that it has applications for green materials. Well, […]

draths.jpgWe’ve been hearing bits and pieces about Draths Corp., a bio-chemical engineering startup, in various speeches from venture investor Vinod Khosla. He hasn’t divulged too much information about the company, only that it was in his portfolio and that it has applications for green materials. Well, a regulatory filing about Khosla’s investment in Draths was picked up by PeHub.com this weekend, so hopefully we’ll start to hear a lot more.

The filing says that Draths has secured $2.5 million of a $5 million Series B round from Khosla Ventures. The Okemos, Mich.-based company also previously raised a seed investment of $1 million from the former chairman and CEO of Intermix Media (MySpace), Brad Greenspan. PeHub says Draths is working on anti-influenza drugs, so the company’s bio-chemistry technology must have a wide range of applications beyond green materials. We contacted the company and are waiting to hear back.

In the meantime, Draths has now officially appeared on Khosla Ventures’ portfolio flower pic — it wasn’t there back in mid-October, when I last looked.

Comments have been disabled for this post